Tuoyo Mene-afejuku, MD, MPH | |
200 1st St Sw, Rochester, MN 55905-4752 | |
(507) 284-2511 | |
Not Available |
Full Name | Tuoyo Mene-afejuku |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 5 Years |
Location | 200 1st St Sw, Rochester, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184076853 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Bridgeport Hospital | Bridgeport, CT | Hospital |
Reading Hospital | West reading, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northeast Medical Group Inc | 1254233836 | 1251 |
Tower Health Medical Group | 7618889213 | 577 |
News Archive
Optimer Pharmaceuticals, Inc. today announced the presentation of two abstracts at the 21st European Congress of Clinical Microbiology and Infectious Diseases conference in Milan, Italy highlighting additional analyses of the Phase 3 data of DIFICID for the treatment of Clostridium difficile infection.
Chromatrap®, a business unit of Porvair Sciences, has developed a new protocol that further extends the many advantages of its popular Chromatin Immunoprecipitation Sequencing (ChIP-seq) assay kits.
National Institute for Children's Health Quality, an independent, nonprofit organization working to improve children's health, today announced the launch of its annual campaign to combat infant mortality in conjunction with Infant Mortality Awareness Month.
The effect of genetics on bone loss rates in postmenopausal women reduces until the age of 65 years, after which time its influence disappears completely, according to results from a twin-based study.
› Verified 7 days ago
Entity Name | Northeast Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
Optimer Pharmaceuticals, Inc. today announced the presentation of two abstracts at the 21st European Congress of Clinical Microbiology and Infectious Diseases conference in Milan, Italy highlighting additional analyses of the Phase 3 data of DIFICID for the treatment of Clostridium difficile infection.
Chromatrap®, a business unit of Porvair Sciences, has developed a new protocol that further extends the many advantages of its popular Chromatin Immunoprecipitation Sequencing (ChIP-seq) assay kits.
National Institute for Children's Health Quality, an independent, nonprofit organization working to improve children's health, today announced the launch of its annual campaign to combat infant mortality in conjunction with Infant Mortality Awareness Month.
The effect of genetics on bone loss rates in postmenopausal women reduces until the age of 65 years, after which time its influence disappears completely, according to results from a twin-based study.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Tuoyo Mene-afejuku, MD, MPH 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Tuoyo Mene-afejuku, MD, MPH 200 1st St Sw, Rochester, MN 55905-4752 Ph: (507) 284-2511 |
News Archive
Optimer Pharmaceuticals, Inc. today announced the presentation of two abstracts at the 21st European Congress of Clinical Microbiology and Infectious Diseases conference in Milan, Italy highlighting additional analyses of the Phase 3 data of DIFICID for the treatment of Clostridium difficile infection.
Chromatrap®, a business unit of Porvair Sciences, has developed a new protocol that further extends the many advantages of its popular Chromatin Immunoprecipitation Sequencing (ChIP-seq) assay kits.
National Institute for Children's Health Quality, an independent, nonprofit organization working to improve children's health, today announced the launch of its annual campaign to combat infant mortality in conjunction with Infant Mortality Awareness Month.
The effect of genetics on bone loss rates in postmenopausal women reduces until the age of 65 years, after which time its influence disappears completely, according to results from a twin-based study.
› Verified 7 days ago
Emily Leasure, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Jorge A Velosa, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Michael Ruediger Mueller, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Mr. Karun Singh Badwal, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Michal Reid, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Katherine Desprez Wick, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Allison Bock, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |